Institutional Ownership
Immunovant Inc
CUSIP 45258J102COMIMVTQ1 2026
13D / 13G Filings
26
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
63.8%
Max % of class reported
Institutional Holders
208
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
26 filings · latest Dec 12, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Dec 12, 2025 | Roivant Sciences Ltd. | 13D/A | 55.9% | — | SEC |
| 2 | Nov 5, 2025 | Fmr LLC | 13G/A | 8.4% | 14.73M | SEC |
| 3 | Apr 21, 2025 | Roivant Sciences Ltd. | 13D/A | 56.9% | — | SEC |
| 4 | Mar 26, 2025 | Deep Track Capital, LP | 13G | 5.6% | 9.50M | SEC |
| 5 | Mar 7, 2025 | Fmr LLC | 13G/A | 10.1% | 17.08M | SEC |
| 6 | Jan 15, 2025 | Roivant Sciences Ltd. | 13D/A | 56.9% | — | SEC |
| 7 | Nov 12, 2024 | Fmr LLC | 13G/A | 8.6% | — | SEC |
| 8 | Feb 14, 2024 | Deep Track Capital, LP | 13G/A | 0.7% | 1.00M | SEC |
| 9 | Feb 9, 2024 | Fmr LLC | 13G | 5.4% | — | SEC |
| 10 | Oct 4, 2023 | Roivant Sciences Ltd. | 13D/A | 55.3% | 79.82M | SEC |
16 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Immunovant Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 16.95M | $420.99M |
| 2 | Deep Track Capital, LP | 11.53M | $286.33M |
| 3 | Blackrock, Inc. | 6.57M | $163.31M |
| 4 | Baker Bros. Advisors LP | 5.46M | $135.57M |
| 5 | State Street Corp | 4.54M | $112.72M |
| 6 | Tcg Crossover Management, LLC | 4.46M | $110.74M |
| 7 | Morgan Stanley | 3.88M | $96.30M |
| 8 | Armistice Capital, LLC | 3.56M | $88.55M |
| 9 | Two Seas Capital LP | 3.20M | $79.54M |
| 10 | Jennison Associates LLC | 3.20M | $79.41M |